Ambofoz

Ambofoz is a combination inhaler containing Beclometasone Dipropionate and Formoterol Fumarate, designed for respiratory conditions. It combines anti-inflammatory and bronchodilator effects for effective asthma and COPD management.

Ambofoz is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). The Beclometasone Dipropionate component helps reduce inflammation in the airways, while Formoterol Fumarate acts as a bronchodilator to improve breathing. This combination is often prescribed for individuals who require both anti-inflammatory and bronchodilator therapy.

Common effects of Ambofoz may include a reduction in asthma symptoms such as wheezing, shortness of breath, and coughing. Some users may experience mild side effects like throat irritation or hoarseness. It is important to use the inhaler as directed to achieve the best results.

Ambofoz should be used under medical supervision. It is important to rinse your mouth after each use to prevent throat irritation. Individuals with certain medical conditions, such as heart disease or diabetes, should consult their healthcare provider before using this medication.

Ambofoz may interact with other medications, including certain asthma treatments, beta-blockers, and some antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol should be discussed with a healthcare professional.